Contract 1422595

The Nebraska Department of Veterans Affairs awarded a contract to McKesson Drug Company, headquartered in Dallas, Texas, effective March 5, 2026, with a contract completion date of January 1, 2099. The contract, identified as 1422595 and classified as Contract Type ZO, carries a total contract amount of $1,029.35. The extended performance period spanning approximately 73 years suggests a standing supply or framework agreement arrangement typical of pharmaceutical distribution contracts within the veterans affairs sector.

McKesson Drug Company, as prime contractor, will deliver pharmaceuticals and related drug distribution services to support the Department of Veterans Affairs operations in Nebraska. The contract structure and extended timeline indicate this is likely a master supply agreement establishing terms and conditions for ongoing pharmaceutical procurement to service veterans health care needs across the state. Specific performance locations and detailed service specifications are not detailed in the available contract documentation.